About VDyne
COMPANY OVERVIEW
VDyne is a clinical-stage medical device company dedicated to developing transcatheter valve solutions for the treatment of debilitating and life-threatening Tricuspid Regurgitation (TR).
Our proprietary technology is – quite literally – turning twenty years of transcatheter valve delivery on its side. Our minimally invasive side-delivery technology enables physicians to treat more TR patients than ever before.
VDyne is undertaking multiple clinical studies in the United States, Europe, and Australia.
VDyne is based in Minneapolis, Minnesota.
VDYNE LEADERSHIP TEAM
Mike Buck
Chief Executive
Officer
Neela Saikrishnan
Senior Vice President,
Prod. Dev. & Operations
Vinny Podichetty, MD
Vice-President
Clinical Affairs
Rick Theisen
Vice-President
Operations
Erik Kari
Senior Director
Quality Assurance
Tony Hyk
Chief Financial
Officer
Scott Kramer
Director
R&D
Sarah Boundy Wong
Director
Regulatory Affairs
Lance Scott
Head of
Marketing
The VDyne Valve System is an investigational product only that is presently undertaking human (clinical) feasibility studies. The VDyne System is not approved for sale or use for the treatment of any health condition.